1. Home
  2. HCAT vs XOMA Comparison

HCAT vs XOMA Comparison

Compare HCAT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCAT
  • XOMA
  • Stock Information
  • Founded
  • HCAT 2008
  • XOMA 1981
  • Country
  • HCAT United States
  • XOMA United States
  • Employees
  • HCAT N/A
  • XOMA 13
  • Industry
  • HCAT Computer Software: Programming Data Processing
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCAT Technology
  • XOMA Health Care
  • Exchange
  • HCAT Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • HCAT 259.8M
  • XOMA 330.2M
  • IPO Year
  • HCAT 2019
  • XOMA N/A
  • Fundamental
  • Price
  • HCAT $4.10
  • XOMA $25.82
  • Analyst Decision
  • HCAT Buy
  • XOMA Strong Buy
  • Analyst Count
  • HCAT 11
  • XOMA 2
  • Target Price
  • HCAT $8.00
  • XOMA $69.50
  • AVG Volume (30 Days)
  • HCAT 672.5K
  • XOMA 71.2K
  • Earning Date
  • HCAT 08-06-2025
  • XOMA 08-12-2025
  • Dividend Yield
  • HCAT N/A
  • XOMA N/A
  • EPS Growth
  • HCAT N/A
  • XOMA N/A
  • EPS
  • HCAT N/A
  • XOMA N/A
  • Revenue
  • HCAT $311,274,000.00
  • XOMA $42,909,000.00
  • Revenue This Year
  • HCAT $11.23
  • XOMA $70.91
  • Revenue Next Year
  • HCAT $9.71
  • XOMA $14.00
  • P/E Ratio
  • HCAT N/A
  • XOMA N/A
  • Revenue Growth
  • HCAT 4.88
  • XOMA 638.41
  • 52 Week Low
  • HCAT $3.49
  • XOMA $18.35
  • 52 Week High
  • HCAT $9.24
  • XOMA $35.00
  • Technical
  • Relative Strength Index (RSI)
  • HCAT 48.15
  • XOMA 50.55
  • Support Level
  • HCAT $3.65
  • XOMA $25.20
  • Resistance Level
  • HCAT $3.93
  • XOMA $28.09
  • Average True Range (ATR)
  • HCAT 0.22
  • XOMA 1.19
  • MACD
  • HCAT 0.00
  • XOMA 0.06
  • Stochastic Oscillator
  • HCAT 40.91
  • XOMA 42.92

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: